Current Liabilities 更改
Acadia Pharmaceuticals USD 330.6M 76.34M 2024-03
ALKERMES USD 458.98M 56.7M 2024-03
Alnylam Pharmaceuticals USD 941.71M 26.08M 2024-03
Biogen USD 3.22B 211.5M 2024-03
BioMarin Pharmaceutical USD 1.09B 89.12M 2024-03
Bristol-Myers Squibb USD 25.82B 2.36B 2024-03
Corcept Therapeutics USD 97.2M 7.3M 2024-03
Cytokinetics USD 88.85M 13.82M 2024-03
Eisai JPY 277.78B 29.52B 2023-12
Eli Lilly USD 18.6B 3.4B 2024-03
Incyte USD 1.4B 156.07M 2024-03
Intra Cellular Therapies USD 134.8M 11.26M 2024-03
J&J USD 48.72B 4.36B 2024-03
Moderna USD 2.38B 635M 2024-03
Neurocrine Biosciences USD 712.9M 21.3M 2024-03
Pfizer USD 40.5B 9.36B 2024-03
Prothena USD 43.27M 13.62M 2024-03
PTC Therapeutics USD 574.55M 28.55M 2024-03
Sarepta Therapeutics USD 608.71M 157.97M 2024-03
Ultragenyx Pharmaceutical USD 245.58M 8.4M 2024-03
Vertex Pharmaceuticals USD 3.8B 196.5M 2024-03



Acadia Pharmaceuticals 流动负债 - 当前值,历史数据,预测,统计,图表和经济日历 - Jun 2024.